Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,289,903 papers from all fields of science
Search
Sign In
Create Free Account
Emepronium
Known as:
Benzenepropanaminium, N-ethyl-N,N,alpha-trimethyl-gamma-phenyl-
, Emepronium [Chemical/Ingredient]
A muscarinic antagonist used mainly in the treatment of urinary syndromes. It is incompletely absorbed from the gastrointestinal tract and does not…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
14 relations
Narrower (4)
Cetiprin
Emepronium Bromide
Preparyl
emepronium carrageenate
In Blood
agonists
analogs & derivatives
antagonists & inhibitors
Expand
Broader (3)
Muscarinic Antagonists
Parasympatholytics
Urological Agents
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Renal, biliary and intestinal clearance of a quaternary ammonium compound, emepronium in the dog.
B. Hallén
,
A. Sundwall
,
C. Elwin
,
J. Vessman
Acta Pharmacologica et Toxicologica
2009
Corpus ID: 46001666
Different routes of elimination of emepronium have been quantitated in conscious and anaesthetized dogs. Smoothed plasma…
Expand
2009
2009
Metabolic disposition of emepronium in the dog with a note on the relationship between plasma concentration and effect.
A. Sundwall
,
K. Uthne
,
J. Vessman
Acta Pharmacologica et Toxicologica
2009
Corpus ID: 41373958
The fate of emepronium (cetiprin®) in the dog has been studied following different routes of administration. The drug is rather…
Expand
1991
1991
Effects of different drugs on the cystometrogram in conscious rats.
L. Guarneri
,
R. Cova
,
P. Angelico
,
E. Colli
,
R. Testa
Pharmacological Research
1991
Corpus ID: 12557730
1982
1982
Urinary incontinence in old age. A controlled clinical trial of emepronium bromide.
S. Walter
,
J. Hansen
,
L. Hansen
,
E. Maegaard
,
H. Meyhoff
,
J. Nordling
British Journal of Urology
1982
Corpus ID: 43315954
The effect of the anticholinergic agent, emepronium bromide (Cetiprin), was studied in a double blind crossover study of a group…
Expand
1981
1981
A trial of emepronium bromide for the treatment of urinary incontinence in the elderly mentally ill.
Williams Aj
,
Prematalake Jk
,
Palmer Rl
1981
Corpus ID: 77823359
A double-blind controlled trial was conducted of emepronium bromide against placebo in elderly mentally ill patients in hospital…
Expand
1980
1980
Oesophageal ulceration due to emepronium bromide.
Barrison Ig
,
Trewby Pn
,
Kan Sp
1980
Corpus ID: 56918651
: Four cases of oesophageal damage associated with ingestion of the urinary anti-spasmodic agent emepronium bromide are described…
Expand
1980
1980
Esophageal lesions caused by orally administered drugs. An experimental study in the cat.
B. Carlborg
,
O. Densert
European surgical research. Europaische…
1980
Corpus ID: 46787819
This article presents an experimental method using cats for investigation of the local ulcerogenic properties of oral drugs in…
Expand
1978
1978
Treatment of Female Incontinence with Emepronium Bromide
S. Hebjørn
,
S. Walter
1978
Corpus ID: 71398535
For more than 20 years emepronium bromide has been used in the treatment of urgency and urge incontinence. Different dosages have…
Expand
1976
1976
Emepronium Bromide (Cetiprin) as a Postoperative Spasmolytic Agent in Transvesical Prostatectomy.
J. H. Syversen
,
E. Mollestad
,
L. Semb
Scandinavian Journal of Urology and Nephrology
1976
Corpus ID: 205968507
To find out whether Cetiprin reduces the vesical spasms seen after cystotomias, a double-blind investigation including 22 men was…
Expand
1969
1969
Clinical Trial of Emepronium Bromide in Nocturnal Frequency of Old Age
J. Brocklehurst
,
J. B. Dillane
,
J. Fry
,
P. Armitage
British medical journal
1969
Corpus ID: 19628033
A double-blind cross-over trial of emepronium bromide (Cetiprin) in nocturnal frequency of micturition in a group of elderly…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE